IP Library Granted Patent US 12661427
Granted Patent B2
US 12661427 · App. 18/555,911 · Granted Jun 23, 2026

Self-adhesive absorbable biological patch and preparation method and use thereof

Inventors: Yiqian Huang (Daxing District, CN); Pengfei Wei (Daxing District, CN); Wei Jing (Daxing District, CN); Xueqiao Yu (Daxing District, CN); Yan Zhang (Daxing District, CN); Bo Zhao (Daxing District, CN)
Assignee: Beijing Biosis Healing Biological Technology Co., Ltd.
A61L24/043A61F2/0063A61L15/325A61L15/40A61L15/44A61L15/585A61L15/64A61L24/0015A61L24/0042
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12661427
App. No.
18/555,911
Granted
Jun 23, 2026
Kind
B2
Abstract

In view of the shortcomings of low tissue adhesiveness or low tissue compliance and the problems of about low operability and inadequate convenience and portability of current tissue sealing materials, the present application provides an absorbable biological patch with self-adhesiveness, comprising a substrate layer and an adhesive coating located on the substrate layer, wherein the substrate layer is a biological material, and the adhesive coating is a succinimidyl ester group-grafted polyacrylic crosslinked copolymer, and optionally comprises a biodegradable polymer. The biological patch can be adhered firmly to the tissue surface and applied directly without extra preparation, and has good biocompatibility, has biodegradability, and can be used in common clinical scenarios such as tissue adherence, wound hemostasis, and low-pressure leakage of body fluids.

Claims (34)

1 . A self-adhesive absorbable biological patch, comprising a substrate layer and an adhesive coating located on the substrate layer, wherein the substrate layer is a biological material; the adhesive coating comprises a succinimidyl ester group-grafted polyacrylic crosslinked copolymer, and further comprises an additional biodegradable polymer; and the crosslinked copolymer is formed by polymerizing and crosslinking acrylic acid and/or acrylamide with an acrylated biodegradable polymer and acrylic acid-N-succinimidyl ester.

2 . The self-adhesive absorbable biological patch according to claim 1 , wherein a weight ratio of acrylic acid and/or acrylamide, the acrylated biodegradable polymer, and acrylic acid-N-succinimidyl ester as three monomers in the crosslinked copolymer is (50 to 300):(2 to 50):(1 to 50), or (200 to 300):(2 to 30):(1 to 20), or (200 to 300):(2 to 10):(1 to 10).

3 . The self-adhesive absorbable biological patch according to claim 2 , wherein a weight ratio of the crosslinked copolymer to the additional biodegradable polymer in the adhesive coating is (1 to 8):(0 to 3), or (2 to 8):(1 to 3), or (2.7 to 4.3):(1 to 1.5).

4 . The self-adhesive absorbable biological patch according to claim 1 , wherein an amount of the crosslinked copolymer in the adhesive coating is 4 to 120 mg/cm 2 , or 10 to 80 mg/cm 2 , or 20 to 40 mg/cm 2 .

5 . The self-adhesive absorbable biological patch according to claim 4 , wherein an amount of the biodegradable polymer in the adhesive coating is 0 to 30 mg/cm 2 , or 1 to 20 mg/cm 2 , or 5 to 10 mg/cm 2 .

6 . The self-adhesive absorbable biological patch according to claim 1 , wherein the adhesive coating further contains an additional active substance.

7 . The self-adhesive absorbable biological patch according to claim 1 , wherein the substrate layer is the biological material containing a collagen protein.

8 . The self-adhesive absorbable biological patch according to claim 7 , wherein the substrate layer is submucosa, dermis, pericardium, collagen, or gelatin.

9 . The self-adhesive absorbable biological patch according to claim 7 , wherein the substrate layer is decellularized small intestinal submucosa, decellularized dermis or decellularized pericardium;

wherein the substrate layer has a thickness of 0.01 mm to 1 mm, or 0.08 mm to 0.3 mm;

the substrate layer is a homogeneous layer;

the substrate layer is in the form of a laminate formed by two or more separated layers; and/or

the substrate layer is composed of 2 to 9 layers of the decellularized small intestinal submucosa.

10 . A kit comprising a substrate layer; and the precursor solution mixture according to claim 9 , wherein each of the substrate layer and the precursor solution mixture are individually packaged, and wherein the substrate layer is a biological material.

11 . A method of preparing a self-adhesive absorbable biological patch according to claim 1 , comprising preparing a precursor solution mixture; and coating the precursor solution mixture on the substrate layer in a coating amount of 10 to 300 μL/cm 2 ;

wherein the precursor solution mixture comprises, based on a total mass of the mixture, 5.0 to 30.0 wt. % of acrylic acid and/or acrylamide, 0.2 to 5.0 wt. % of acrylated biodegradable polymer, 0.1 to 5.0 wt. % of acrylic acid-N-succinimidyl ester, 0 to 15.0 wt. % of biodegradable polymer, and a crosslinking amount of crosslinking agent.

12 . The method according to claim 11 , wherein:

the method further comprises a step of subjecting an adhesive coating to crosslinking treatment to fully polymerize and crosslink the adhesive coating;

the method further comprises subjecting the adhesive coating to dialysis treatment; and/or

the method further comprises subjecting the self-adhesive absorbable biological patch to dehydration treatment.

13 . A dry adhesive material for bonding a tissue surface, comprising a succinimidyl ester group-grafted polyacrylic crosslinked copolymer, and further comprising a biodegradable polymer; wherein the crosslinked copolymer is formed by polymerizing and crosslinking acrylic acid and/or acrylamide with an acrylated biodegradable polymer and acrylic acid-N-succinimidyl ester.

14 . The dry adhesive material according to claim 13 , wherein a weight ratio of acrylic acid and/or acrylamide, the acrylated biodegradable polymer, and acrylic acid-N-succinimidyl ester as three monomers in the crosslinked copolymer is (50 to 300):(2 to 50):(1 to 50), or (200 to 300):(2 to 30):(1 to 20), or (200 to 300):(2 to 10):(1 to 10).

15 . The dry adhesive material according to claim 13 , wherein a weight ratio of the crosslinked copolymer to the biodegradable polymer in the dry adhesive material is (1 to 8):(0 to 3), or (2 to 8):(1 to 3), or (2.7 to 4.3):(1 to 1.5);

wherein an amount of the crosslinked copolymer in the dry adhesive material is 4 to 120 mg/cm 2 , or 10 to 80 mg/cm 2 , or 20 to 40 mg/cm 2 ;

an amount of the biodegradable polymer in the dry adhesive material is 0 to 30 mg/cm 2 , or 1 to 20 mg/cm 2 , or 5 to 10 mg/cm 2 ; and/or

the dry adhesive material further contains an additional active material.

16 . A precursor solution mixture comprising, based on a total mass of the mixture, 5.0 to 30.0 wt. % of acrylic acid and/or acrylamide, 0.2 to 5.0 wt. % of acrylated biodegradable polymer, 0.1 to 5.0 wt. % of acrylic acid-N-succinimidyl ester, 0 to 15.0 wt. % of biodegradable polymer, and a crosslinking amount of crosslinking agent.

17 . A kit comprising a substrate layer; and the precursor solution mixture according to claim 9 , wherein each of the substrate layer and the precursor solution mixture are individually packaged, and wherein the substrate layer is a biological material.

18 . The precursor solution mixture according to claim 16 , wherein:

the content of acrylic acid and/or acrylamide is 10.0 to 30.0 wt. %, or 20.0 to 30.0 wt. %;

the content of the acrylated biodegradable polymer is 0.5 to 4.0 wt. %, or 1.0 to 3.0 wt. %;

the content of acrylic acid-N-succinimidyl ester is 0.5 to 3.0 wt. %, or 0.8 to 1.2 wt. %;

the content of the biodegradable polymer is 5.0 to 15.0 wt. %, or 8.0 to 12.0 wt. %; and/or

the content of the crosslinking agent is 0.1 to 0.3 wt. %.